Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.33 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28284269 | 1.00 | GSR (0.44) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL29233121 | 1.00 | GSR (0.44) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL25173868 | 0.92 | GNAI3 (0.46) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL28284288 | 0.92 | GNAI3 (0.46) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL29233072 | 0.92 | GNAI3 (0.46) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL6432150 | 0.92 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5670259 | 0.92 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL29233108 | 0.91 | GNAI3 (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL25173617 | 0.91 | GNAI3 (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Hydrochloric Acid SCHEMBL5846878 | 0.90 | GSR (0.50) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894064-B1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH & CIE (CH) | 2023-11-15 | — | — | EP | claimed |
| US-20220072498-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2022-03-10 | — | — | US | claimed |
| EP-3894064-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2021-10-20 | — | — | EP | claimed |
| CN-113329812-A | Method for preparing microcapsules | 弗门尼舍有限公司 | 2021-08-31 | — | — | CN | claimed |
| WO-2020234262-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2020-11-26 | — | — | WO | claimed |
| EP-3894064-B1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH & CIE (CH) | 2023-11-15 | — | — | EP | disclosed |
| US-20220072498-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2022-03-10 | — | — | US | disclosed |
| EP-3894064-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2021-10-20 | — | — | EP | disclosed |
| CN-113329812-A | Method for preparing microcapsules | 弗门尼舍有限公司 | 2021-08-31 | — | — | CN | disclosed |
| WO-2020234262-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2020-11-26 | — | — | WO | disclosed |
| US-20170121278-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC INC (US) | 2017-05-04 | — | — | US | disclosed |
| US-9573889-B2 | Methods and compositions for making an amino acid triisocyanate | WARSAW ORTHOPEDIC, INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160168085-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC INC (US) | 2016-06-16 | — | — | US | disclosed |
| US-9266824-B2 | Methods and compositions for making an amino acid triisocyanate | WARSAW ORTHOPEDIC, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150197483-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE | WARSAW ORTHOPEDIC, INC. (US) | 2015-07-16 | — | — | US | disclosed |
| US-20150197488-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC, INC. (US) | 2015-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121278-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885GNAI3 2200/4885GNAO1 2579/4885 |
| US-20150197483-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE | ALKBH3, AADAT, ALKBH1 | GSR 4740/4885GNAI3 2467/4885GNAO1 2526/4885 |
| US-20150197488-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885GNAI3 2200/4885GNAO1 2579/4885 |
| US-20160168085-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885GNAI3 2200/4885GNAO1 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.